DV

Devang Verma

Active Director Director DIN 09634882
DIN 09634882 First appointment Jun 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Devang Verma

Data last updated:

Devang Verma is a Director at Kemiras Drugs Private Limited (since 2022). The company operates in Chemicals. Kemiras Drugs Private Limited reported revenue of ₹24.7 Lakh (FY 2025).

DIN 09634882
Primary Designation Director
Industry Chemicals
First Appointment 14 Jun 2022
Oldest Company Age 6 yrs
Largest company Kemiras Drugs Private Limited · ₹24.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kemiras Drugs Private Limited U24290UP2020PTC135201
Director14 Jun 20222020₹24.7 Lakh (FY 2025)Active

Board colleagues of Devang Verma

Directorship timeline

Open interactive timeline →
Kemiras Drugs Private Limited
Premium access

Shareholding and investment profile for Devang Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devang Verma

Devang Verma currently holds 1 directorship: Kemiras Drugs Private Limited (Director, since 14 Jun 2022, revenue ₹24.7 Lakh (FY 2025)).

Devang Verma was first appointed on 14 Jun 2022 as Director at Kemiras Drugs Private Limited.

The current boards of Devang Verma's companies include Beena Verma (Kemiras Drugs Private Limited), Dadhich Kumar Verma (Kemiras Drugs Private Limited), Rama Shankar Verma (Kemiras Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available